Follow the 通化东宝 share price and the full management transaction log of the company, a publicly traded company based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 通化东宝 has logged 2 insider filings. Market capitalisation: €16.4bn. The latest transaction was filed on 13 November 2024 (Purchase). Among the most active insiders: 王君业. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Tonghua Dongbao es una empresa del sector de la salud y farmacéutico, que cotiza en la Bolsa de Shanghái. Se centra en la investigación, el desarrollo y la producción de medicamentos, particularmente para el tratamiento de la diabetes.